Drug class
Anticoagulant Reversal Agent for Factor Xa Inhibitors
Anticoagulant reversal agents for factor Xa inhibitors are a specialized therapeutic class of antidotes designed to neutralize the pharmacodynamic activity of oral and parenteral factor Xa inhibitors. Read more about Anticoagulant Reversal Agent for Factor Xa Inhibitors
0 drugs in this class 0 manufacturers
Drugs in Anticoagulant Reversal Agent for Factor Xa Inhibitors
No drugs are available
This class does not currently contain public drugs.
Anticoagulant reversal agents for factor Xa inhibitors are a specialized therapeutic class of antidotes designed to neutralize the pharmacodynamic activity of oral and parenteral factor Xa inhibitors.
Specifically exemplified by the recombinant decoy protein andexanet alfa, these agents work by binding and sequestering free factor Xa inhibitors with high affinity, thereby restoring endogenous thrombin generation and normal hemostatic capacity.
Clinically, this class is utilized in acute critical care and emergency settings to rapidly halt anticoagulation in patients experiencing life-threatening or uncontrolled hemorrhage, most commonly major gastrointestinal bleeding or intracranial hemorrhage.
-
nih.gov
Anticoagulant reversal agents for factor Xa inhibitors are a specialized therapeutic class of antidotes designed to neutralize the pharmacodynamic activity of oral and parenteral factor Xa inhibitors
-
nih.gov
Anticoagulant reversal agents for factor Xa inhibitors are a specialized therapeutic class of antidotes designed to neutralize the pharmacodynamic activity of oral and parenteral factor Xa inhibitors
-
pace-cme.org
Specifically exemplified by the recombinant decoy protein andexanet alfa, these agents work by binding and sequestering free factor Xa inhibitors with high affinity, thereby restoring endogenous thrombin generation and normal hemostatic capacity
-
acc.org
Specifically exemplified by the recombinant decoy protein andexanet alfa, these agents work by binding and sequestering free factor Xa inhibitors with high affinity, thereby restoring endogenous thrombin generation and normal hemostatic capacity
-
fda.gov
Clinically, this class is utilized in acute critical care and emergency settings to rapidly halt anticoagulation in patients experiencing life-threatening or uncontrolled hemorrhage, most commonly major gastrointestinal bleeding or intracranial hemorrhage
-
uic.edu
Clinically, this class is utilized in acute critical care and emergency settings to rapidly halt anticoagulation in patients experiencing life-threatening or uncontrolled hemorrhage, most commonly major gastrointestinal bleeding or intracranial hemorrhage
-
nih.gov
Clinically, this class is utilized in acute critical care and emergency settings to rapidly halt anticoagulation in patients experiencing life-threatening or uncontrolled hemorrhage, most commonly major gastrointestinal bleeding or intracranial hemorrhage
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.